0001209191-19-049538.txt : 20190913
0001209191-19-049538.hdr.sgml : 20190913
20190913185827
ACCESSION NUMBER: 0001209191-19-049538
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190912
FILED AS OF DATE: 20190913
DATE AS OF CHANGE: 20190913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROBIN SHERRINGTON
CENTRAL INDEX KEY: 0001619962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 191093466
MAIL ADDRESS:
STREET 1: C/O XENON PHARMACEUTICALS INC.
STREET 2: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G4W8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-12
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001619962
ROBIN SHERRINGTON
200 - 3650 GILMORE WAY
BURNABY
A1
BRITISH COLUMBIA, CANADA
0
1
0
0
EVP, Strategy & Innovation
Common Shares
2019-09-12
4
M
0
6172
3.07
A
12064
D
Common Shares
2019-09-12
4
F
0
1868
9.38
D
10196
D
Stock Option (Right to Buy)
3.07
2019-09-12
4
M
0
6172
0.00
D
2019-09-18
Common Shares
6172
0
D
The exercise price was converted to U.S. dollars from $3.74 CAD using the closing rate of exchange on the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the day of exercise.
Represents the closing price of the Company's common shares on September 11, 2019, which was converted to a Canadian dollar amount for purposes of net settlement calculations.
The shares subject to the option fully vested on December 31, 2012. The date the options became fully vested was incorrectly reflected on the Reporting Person's Form 3.
/s/ Sherry Aulin, Attorney-in-fact
2019-09-13